Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
April 11, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
February 22, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 08, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Provides 2024 Financial Guidance
January 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
November 27, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces $25 Million Accelerated Share Repurchase Program
November 09, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in Upcoming Investor Conferences
November 08, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
August 28, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
August 24, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces $50 Million Accelerated Share Repurchase Program
August 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
August 03, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
July 20, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in Jefferies Healthcare Conference
June 01, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports First Quarter 2023 Financial Results
May 04, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
April 20, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
February 23, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
February 22, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
February 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
February 06, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
February 06, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Provides 2023 Financial Guidance
January 04, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
December 22, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022
October 20, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.